HBA1 (Center) Rabbit Polyclonal Antibody AP52006PU-N from OriGene Technologies | Biocompare.com

Supplier Images

HBA1 (Center) Rabbit Polyclonal Antibody

Be the first to write a review!

Citations:

Supplier Page from
OriGene Technologies for
HBA1 (Center) Rabbit Polyclonal Antibody

The HBA1 (Center) Rabbit Polyclonal Antibody from OriGene Technologies is a Rabbit Polyclonal antibody. This antibody recognizes Human, and Mouse antigen. The HBA1 (Center) Rabbit Polyclonal Antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, and Western Blot.

Description

HBA1 (Center) rabbit polyclonal antibody, Aff - Purified

Product Specs
ItemHBA1 (Center) Rabbit Polyclonal Antibody
CompanyOriGene Technologies
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberAP52006PU-N
Quantity200 µl
ApplicationsFC, IHC, WB
Concentrationlot specific
Conjugate/TagUnconjugated
PurityProtein A column, followed by peptide affinity purification
ReactivityHuman, Mouse
TargetHBA2
IsotypeIg
HostRabbit
Antibody TypePrimary Antibodies
ImmunogenKLH conjugated synthetic peptide between 100~128 amino acids from the Central region of human Hemoglobin alpha
Domain/Region/TerminusCenter
Brand/TrademarkAcris Antibodies GmbH
NCBI Full Gene Namehemoglobin subunit alpha 1
NCBI Gene AliasesHBA-T3, ECYT7, HBH, METHBA
ClonalityPolyclonal
TypePrimary Antibodies
FormatPBS containing 0.09% (W/V) Sodium Azide as preservative
State: Aff - Purified
State: Liquid purified Ig fraction

Add to Compare List

OriGene Technologies

OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

Company Profile

Website: http://www.origene.com

(1) Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysmMechanisms of ageing and developmentJuly 1, 2021Teti G, Chiarini F, Mazzotti E, Ruggeri A, Carano F, Falconi M.

(2) Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitorsPainFebruary 1, 2020Potenzieri A, Riva B, Rigolio R, Chiorazzi A, Pozzi E, Ballarini E, Cavaletti G, Genazzani AA.

Be the First to Write a Review!